tiprankstipranks
Advertisement
Advertisement
Eikon Therapeutics price target lowered to $5 from $7 at Wedbush
PremiumThe FlyEikon Therapeutics price target lowered to $5 from $7 at Wedbush
2M ago
Premium
Ratings
Analyst Reiterates Buy on Eikon Therapeutics, Maintaining $29 December 2026 Price Target on Emerging Oncology Pipeline
2M ago
Premium
Company Announcements
Eikon Therapeutics Highlights Q1 2026 Results and Pipeline
2M ago
Eikon Therapeutics initiated with an Overweight at JPMorgan
PremiumThe FlyEikon Therapeutics initiated with an Overweight at JPMorgan
4M ago
Eikon Therapeutics initiated with an Overweight at Morgan Stanley
Premium
The Fly
Eikon Therapeutics initiated with an Overweight at Morgan Stanley
4M ago
Spotify upgraded, First Solar downgraded: Wall Street’s top analyst calls
Premium
The Fly
Spotify upgraded, First Solar downgraded: Wall Street’s top analyst calls
4M ago
Eikon Therapeutics opens at $17.05, IPO priced at $18.00
PremiumThe FlyEikon Therapeutics opens at $17.05, IPO priced at $18.00
5M ago
Eikon Therapeutics indicated to open at $17.92, IPO priced at $18 per share
Premium
The Fly
Eikon Therapeutics indicated to open at $17.92, IPO priced at $18 per share
5M ago
Eikon Therapeutics 21.18M share IPO priced at $18.00
Premium
The Fly
Eikon Therapeutics 21.18M share IPO priced at $18.00
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100